Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021

RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline during ASH 2021,” said Peter Lebowitz, M.D., Ph.D., Global Therapeutic Area Head, Oncology, Janssen Research & Development, LLC. “We continue to deepen and accelerate our understanding of blood cancers as we strive toward our vision – the elimination of cancer.”“As evidenced by our presence at ASH, we are continuously pushing boundaries to treat cancer,” said Serge Messerlian, U.S. President, Oncology, Janssen Biotech, Inc. “At ASH, we look forward to working with the oncology community to advance the understanding and use of novel treatments and address unmet patient needs, with the ultimate goal of developing curative therapies. Our commitment to the blood cancer community is driven and inspired by our mission to reimagine care so patients can redefine living.”Transforming treatment paradigms for patients with multiple myelomaThrough years of res...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
More News: Acetaminophen | Acute Leukemia | Allergy & Immunology | Amyloidosis | Anaphylactic Shock | Anemia | Anesthesia | Anesthesiology | Antiphospholipid Syndrome | Arrhythmia | Aspirin | Atrial Fibrillation | Autoimmune Disease | Babies | Babies Heart Conditions | Back Pain | Biotechnology | Bladder Cancer | Bleeding | Blood Transusion | Brain | Brain Cancers | Breast Carcinoma | Breastfed | Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Cardiac Arrhythmia | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Child Development | Children | China Health | Chronic Leukemia | Chronic Lymphocytic Leukemia | Chronic Obstructive Pulmonary | Chronic Pain | Clinical Trials | Clopidogrel | Complementary Medicine | Constipation | Corticosteroid Therapy | Cough | Coumadin | Dentistry | Dexamethasone | Diabetes | Diabetes Type 2 | Emergency Medicine | Endocrinology | Environmental Health | Epistaxis (Nosebleeds) | European Medicines Agency (EMA) | Food and Drug Administration (FDA) | Gastroenterology | Genetics | Georgia Health | Grants | Hay Fever | Headache | Health Management | Heart | Heart Attack | Heart Transplant | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Hematology | Hemorrhagic Stroke | Hepatocellular Carcinoma | Herbs | Hormones | Hospitals | Hughes Syndrome | Hypertension | Immunotherapy | Incontinence | Infectious Diseases | Insomnia | Kidney Transplant | Kidney Transplantation | Laboratory Medicine | Laryngeal Cancer | Learning | Legislation | Leukemia | Liver | Liver Cancer | Liver Transplant | Lortab | Lung Transplant | Lymphoma | Macroglobulinemia | Marketing | Melanoma | Men | Migraine | Milk | Molecular Biology | Myasthenia Gravis | Myeloma | Neurology | Neuroscience | Neurosurgery | Nonmelanoma Skin Cancer | Oral Cancer | Pain | Pain Management | Perinatology & Neonatology | Peripheral Vascular Disease (PVD) | Pharmaceuticals | Plavix | Pneomococcal Vaccine | Pneumonia | Politics | Prednisone | Pregnancy | Primary CNS Lymphoma | Profits and Losses | Pulmonary Hypertension | Pulmonary Thromboembolism | Respiratory Medicine | Revlimid | Rituxan | Science | Skin | Skin Cancer | Skin Graft | Sodium | Stem Cell Therapy | Stem Cells | Stroke | Study | Thrombocytopenia | Thrombosis | Toxicology | Transplant Surgery | Transplants | Universities & Medical Training | Urology & Nephrology | Vaccines | Velcade | Veterinary Vaccinations | Vitamins | Waldenstrom's Macroglobulinemia | Warfarin | Warnings | Women